...
首页> 外文期刊>cns drugs >Antibacterial Therapy of NeurosyphilisLack of Impact of New Therapies
【24h】

Antibacterial Therapy of NeurosyphilisLack of Impact of New Therapies

机译:Antibacterial Therapy of NeurosyphilisLack of Impact of New Therapies

获取原文
           

摘要

Neurosyphilis is caused by the spirocheteTreponema pallidum. These organisms divide slowly, requiring long exposure to antibacterials for treatment success. In order for an antibacterial to be effective in the therapy of neurosyphilis, it must achieve treponemicidal concentrations in the CSF, have a long half-life and be given in a treatment regimen that favours compliance. Penicillin was first introduced for the treatment of syphilis in 1943, and despite interest in the use of amoxicillin, erythromycin, tetracycline, doxycycline, ceftriaxone and azithromycin, penicillin remains the only recommended antibacterial agent for neurosyphilis.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号